VanEck Pharmaceutical ETF (PPH) |
| 114.06 -1.82 (-1.57%) 08-27 16:00 |
| Open: | 114.495 |
| High: | 115.015 |
| Low: | 113.985 |
| Volume: | 588,690 |
| Market Cap: | 991(M) |
| PE Ratio: | 25.81 |
| Exchange: | NASDAQ |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 137.81 |
| Resistance 1: | 117.99 |
| Pivot price: | 113.82 |
| Support 1: | 111.63 |
| Support 2: | 107.70 |
| 52w High: | 118 |
| 52w Low: | 85.91 |
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 27 Aug 2026
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now - TradingView
Wed, 26 Aug 2026
Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus - The Motley Fool
Tue, 18 Aug 2026
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Motley Fool
Wed, 05 Aug 2026
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
Fri, 17 Jul 2026
Use These ETFs as Health Stocks LLY, UNH, MRK Thrive - ETF Database
Sat, 04 Jul 2026
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP? - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
